Jakarta (ANTARA) - The National Research and Innovation Agency (BRIN) is encouraging genetic research on the human metapneumovirus (HMPV) and the development of rapid diagnostic tests to detect it.
Research is needed to determine the characteristics of the metapneumovirus circulating in Indonesia—whether it is subtype A or B, and whether there are genetic mutations, associate researcher at BRIN's Center for Preclinical and Clinical Medical Research Telly Purnamasari Agus said.
"The development of rapid diagnostic tests to detect HMPV is also needed, especially in areas with limited health facilities," she added here on Thursday.
She further emphasized the need to carry out clinical research on risk factors, disease severity and complications, and treatment management, as well as vaccine development to reduce the impact of HMPV infections.
Research collaboration can be carried out with international organizations such as the World Health Organisation (WHO) and Centers for Disease Control and Prevention (CDC) to determine global trends related to HMPV and efforts to mitigate the spread and impact of cross-country diseases, she added.
To date, she noted, there is no specific vaccination to prevent HMPV. However, several effective preventive efforts can be made, such as maintaining hand hygiene, wearing masks, maintaining distance, and maintaining overall body health.
"These preventive efforts require cooperation from all elements of society as well as (understanding of) the importance of public education for the implementation of HMPV prevention in Indonesia," she said.
Baca juga: Aspek agama bisa arahkan individu peduli pada lingkungan
The HMPV is a virus that causes respiratory tract infections, with symptoms similar to the common flu, such as cough, runny nose, fever, and shortness of breath.
The virus was first identified in 2001, originating from samples of patients who experienced respiratory tract infections.
Baca juga: Antropolog Hilman ungkap penyebab kemiripan budaya satu daerah dengan lainnya
The HMPV is divided into two subtypes, A and B. Each has several subgroups with different characteristics.
Those experiencing symptoms and who are at high risk, such as children, the elderly, people with HIV/AIDS, or people with chronic diseases, have been advised to wear a mask while traveling, especially in crowded places.
